Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism

Corrigendum in: /10.3892/ol.2021.12529
  • Authors:
    • Lingling Si
    • Xinhui Yang
    • Xinyan Yan
    • Yanming Wang
    • Qiusheng Zheng
  • View Affiliations / Copyright

    Affiliations: School of Pharmacy, Shihezi University, Shihezi, Xinjiang 832002, P.R. China, Department of Pharmacy, The First Affiliated Hospital of the Medical College, Xinjiang Shihezi University, Shihezi, Xinjiang 832002, P.R. China
    Copyright: © Si et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 241-249
    |
    Published online on: May 12, 2017
       https://doi.org/10.3892/ol.2017.6159
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate whether an increase in cyclin‑dependent kinase 2 (CDK2) activity is involved in apoptosis of human bladder cancer T24 cells induced by isoliquiritigenin (ISL). The viability of T24 cells was estimated using a sulforhodamine B assay. Cell morphological changes were examined using Hoechst 33258 staining. The apoptotic rate was determined by staining cells with Annexin V‑fluorescein isothiocyanate and propidium iodide labeling. The mitochondrial membrane potential (ΔΨm) was measured using 5,5',6,6'‑tetrachloro‑1,1', 3,3'‑tetraethyl benzimidazole carbocyanine iodide. Alterations in the apoptosis‑related regulators B‑cell lymphoma‑2 (Bcl‑2), Bcl‑2‑associated X protein (Bax), Bcl‑2‑interacting mediator of cell death (Bim), apoptotic protease‑activating facter‑1 (Apaf‑1), caspase‑9 and caspase‑3 were determined using reverse transcription‑polymerase chain reaction (PCR) and quantitative PCR methods. Western blot analysis was used to detect the expression of Bcl‑2, Bax and caspase‑3. CDK2 activity was measured using a spectrometric assay. Following treatment with ISL (between 30 and 70 µg/ml) for 24 h, typical apoptotic morphological changes were observed in T24 cells, exhibiting an edge set of chromosomes, nuclear condensation, nuclear fragmentation and other morphological features. Treatment with ISL increased the apoptotic ratio of T24 cells in a concentration‑dependent manner and induced a decrease in the ΔΨm in a time‑dependent manner. Treatment with ISL upregulated the expression of Bax, Bim, Apaf‑1, caspase‑9 and caspase‑3, downregulated the expression of Bcl‑2, and increased CDK2 activity. MK‑8776 (an inhibitor of CDK2) antagonized the apoptosis induced by ISL, and, compared with treatment with ISL alone, pretreatment with MK‑8776 inhibited the decrease in ΔΨm, downregulated the mRNA expression of Bax, Bim, Apaf‑1, caspase‑9 and caspase‑3, and upregulated Bcl‑2 mRNA expression. Western blot analysis demonstrated that, with increasing ISL concentration, the Bcl‑2 expression level was significantly decreased (P<0.05), whereas caspase‑3 and Bax expression levels were significantly increased (P<0.01). These results indicated that ISL treatment caused a significant decrease in the proliferation rate and increase in apoptosis of T24 cells. The mechanism by which ISL induces T24 cell apoptosis in vitro may be associated with an increase in CDK2 activity, downregulation of the ΔΨm and activation of caspase‑3/caspase‑9‑mediated mitochondrial apoptotic signaling pathways.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

Figure 11

View References

1 

Huang W, Chen Y, Liu Y, Zhang Q, Yu Z, Mou L, Wu H, Zhao L, Long T, Qin D and Gui Y: Roles of ERβ and GPR30 in proliferative response of human bladder cancer cell to estrogen. Biomed Res Int. 2015:2517802015. View Article : Google Scholar : PubMed/NCBI

2 

Yee DS, Ishill NM, Lowrance WT, Herr HW and Elkin EB: Ethnic differences in bladder cancer survival. Urology. 78:544–549. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Parkin DM: International variation. Oncogene. 23:6329–6340. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Braithwaite D, Demb J, Henderson LM, Mandelblatt JS and Kerlikowske K: American Cancer Society: Cancer Facts & Figures. 2016.

5 

Douglass L and Schoenberg M: The future of intravesical drug delivery for non-muscle invasive bladder cancer. Bladder Cancer. 2:285–292. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Jiang J, Yuan X, Zhao H, Yan X, Sun X and Zheng Q: Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production. Biomed Mater Eng. 24:1019–1025. 2014.PubMed/NCBI

7 

Stein JP and Skinner DG: Radical cystectomy for invasive bladder cancer: Long-term results of a standard procedure. World J Urol. 24:296–304. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Peng C, Zeng W, Su J, Kuang Y, He Y, Zhao S, Zhang J, Ma W, Bode AM, Dong Z and Chen X: Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway. Oncogene. 35:1170–1179. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Hu JW, Sun P, Zhang DX, Xiong WJ and Mi J: Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts. Cell Signal. 26:2210–2216. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Jin YH, Yim H, Park JH and Lee SK: Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis. Biochem Biophys Res Commun. 305:974–980. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Kinghorn AD, Pan L, Fletcher JN and Chai H: The relevance of higher plants in lead compound discovery programs. J Nat Prod. 74:1539–1555. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Fintelmann V: Modern phytotherapy and its uses in gastrointestinal conditions. Planta Med. 57 Suppl 7:S48–S52. 1991. View Article : Google Scholar

13 

Madak-Erdogan Z, Gong P, Zhao YC, Xu L, Wrobel KU, Hartman JA, Wang M, Cam A, Iwaniec UT, Turner RT, et al: Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland. Mol Nutr Food Res. 60:369–380. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Fukai T, Marumo A, Kaitou K, Kanda T, Terada S and Nomura T: Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci. 71:1449–1463. 2002. View Article : Google Scholar : PubMed/NCBI

15 

Funakoshi-Tago M, Nakamura K, Tsuruya R, Hatanaka M, Mashino T, Sonoda Y and Kasahara T: The fixed structure of Licochalcone A by alpha, beta-unsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-kappaB activation. Int Immunopharmacol. 10:562–571. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Xiao XY, Hao M, Yang XY, Ba Q, Li M, Ni SJ, Wang LS and Du X: Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett. 302:69–75. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Kim YM, Kim TH, Kim YW, Yang YM, Ryu DH, Hwang SJ, Lee JR, Kim SC and Kim SG: Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition. Free Radic Biol Med. 49:1722–1734. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Yadav VR, Prasad S, Sung B and Aggarwal BB: The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol. 11:295–309. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Chin YW and Kinghorn AD: Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini Rev Org Chem. 5:355–364. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, Zhang J, Peng C, Lin Y and Chen J: MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 5:7013–7026. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Zhao H, Yuan X, Li D, Chen H, Jiang J, Wang Z, Sun X and Zheng Q: Isoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide. Molecules. 18:8786–8798. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Haraguchi H, Ishikawa H, Mizutani K, Tamura Y and Kinoshita T: Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem. 6:339–347. 1998. View Article : Google Scholar : PubMed/NCBI

23 

Fukai T, Satoh K, Nomura T and Sakagami H: Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia. 74:624–629. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Yokota T, Nishio H, Kubota Y and Mizoguchi M: The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 11:355–361. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Inoue H, Mori T, Shibata S and Koshihara Y: Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema. Br J Pharmacol. 96:204–210. 1989. View Article : Google Scholar : PubMed/NCBI

26 

Gerber B, Scholz C, Reimer T, Briese V and Janni W: Complementary and alternative therapeutic approaches in patients with early breast cancer: A systematic review. Breast Cancer Res Treat. 95:199–209. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Kushman ME, Kabler SL, Ahmad S, Doehmer J, Morrow CS and Townsend AJ: Protective efficacy of hGSTM1-1 against B[a]P and (+)- or (−)-B[a]P-7,8-dihydrodiol cytotoxicity, mutagenicity, and macromolecular adducts in V79 cells coexpressing hCYP1A1. Toxicol Sci. 99:51–57. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Soriano J, García-Díaz M, Mora M, Sagristá ML, Nonell S, Villanueva A, Stockert JC and Cañete M: Liposomal temocene (m-THPPo) photodynamic treatment induces cell death by mitochondria-independent apoptosis. Biochim Biophys Acta. 1830:4611–4620. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH and Kolstad A: Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma. BMC Cancer. 12:4782012. View Article : Google Scholar : PubMed/NCBI

30 

Wang T, Song X, Zhang Z, Guo M, Jiang H, Wang W, Cao Y, Zhu L and Zhang N: Stevioside inhibits inflammation and apoptosis by regulating TLR2 and TLR2-related proteins in S. aureus-infected mouse mammary epithelial cells. Int Immunopharmacol. 22:192–199. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Chen X, Zhang B, Yuan X, Yang F, Liu J, Zhao H, Liu L, Wang Y, Wang Z and Zheng Q: Isoliquiritigenin-induced differentiation in mouse melanoma B16F0 cell line. Oxid Med Cell Longev. 2012:5349342012. View Article : Google Scholar : PubMed/NCBI

32 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

33 

Hsu YL, Kuo PL, Lin LT and Lin CC: Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med. 71:130–134. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Kim DC, Ramachandran S, Baek SH, Kwon SH, Kwon KY, Cha SD, Bae I and Cho CH: Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci. 15:552–558. 2008. View Article : Google Scholar : PubMed/NCBI

35 

Jung JI, Chung E, Seon MR, Shin HK, Kim EJ, Lim SS, Chung WY, Park KK and Park JH: Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors. 28:159–168. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H and Okuyama T: Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 95:448–453. 2004. View Article : Google Scholar : PubMed/NCBI

37 

Zhou GS, Song LJ and Yang B: Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro. Mol Med Rep. 7:531–536. 2013.PubMed/NCBI

38 

Choi JS, Shin S, Jin YH, Yim H, Koo KT, Chun KH, Oh YT, Lee WH and Lee SK: Cyclin-dependent protein kinase 2 activity is required for mitochondrial translocation of Bax and disruption of mitochondrial transmembrane potential during etoposide-induced apoptosis. Apoptosis. 12:1229–1241. 2007. View Article : Google Scholar : PubMed/NCBI

39 

Darvin P, Baeg SJ, Joung YH, Sp N, Kang DY, Byun HJ, Park JU and Yang YM: Tannic acid inhibits the Jak2/STAT3 pathway and induces G1/S arrest and mitochondrial apoptosis in YD-38 gingival cancer cells. Int J Oncol. 47:1111–1120. 2015.PubMed/NCBI

40 

Harbour JW, Luo RX, Dei Santi A, Postigo AA and Dean DC: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:859–869. 1999. View Article : Google Scholar : PubMed/NCBI

41 

Adon AM, Zeng X, Harrison MK, Sannem S, Kiyokawa H, Kaldis P and Saavedra H: Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells. Mol Cell Biol. 30:694–710. 2010. View Article : Google Scholar : PubMed/NCBI

42 

Yu L, Ma J, Han J, Wang B, Chen X, Gao C, Li D and Zheng Q: Licochalcone B arrests cell cycle progression and induces apoptosis in human breast cancer MCF-7 Cells. Recent Pat Anticancer Drug Discov. 11:444–452. 2016. View Article : Google Scholar : PubMed/NCBI

43 

Huang J, Lv C, Hu M and Zhong G: The mitochondria-mediate apoptosis of Lepidopteran cells induced by azadirachtin. PLoS One. 8:e584992013. View Article : Google Scholar : PubMed/NCBI

44 

Priyadarsini RV, Murugan RS, Sripriya P, Karunagaran D and Nagini S: The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells. Free Radic Res. 44:624–634. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Si L, Yang X, Yan X, Wang Y and Zheng Q: Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529. Oncol Lett 14: 241-249, 2017.
APA
Si, L., Yang, X., Yan, X., Wang, Y., & Zheng, Q. (2017). Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529. Oncology Letters, 14, 241-249. https://doi.org/10.3892/ol.2017.6159
MLA
Si, L., Yang, X., Yan, X., Wang, Y., Zheng, Q."Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529". Oncology Letters 14.1 (2017): 241-249.
Chicago
Si, L., Yang, X., Yan, X., Wang, Y., Zheng, Q."Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529". Oncology Letters 14, no. 1 (2017): 241-249. https://doi.org/10.3892/ol.2017.6159
Copy and paste a formatted citation
x
Spandidos Publications style
Si L, Yang X, Yan X, Wang Y and Zheng Q: Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529. Oncol Lett 14: 241-249, 2017.
APA
Si, L., Yang, X., Yan, X., Wang, Y., & Zheng, Q. (2017). Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529. Oncology Letters, 14, 241-249. https://doi.org/10.3892/ol.2017.6159
MLA
Si, L., Yang, X., Yan, X., Wang, Y., Zheng, Q."Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529". Oncology Letters 14.1 (2017): 241-249.
Chicago
Si, L., Yang, X., Yan, X., Wang, Y., Zheng, Q."Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin‑dependent kinase‑independent mechanism Corrigendum in /10.3892/ol.2021.12529". Oncology Letters 14, no. 1 (2017): 241-249. https://doi.org/10.3892/ol.2017.6159
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team